Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1623 1633
This examiner grants 52% of resolved cases
Abdulrahman Mustafa Abbas examines applications in Tech Center 1600 and Art Unit 1612. With 61 resolved cases, the examiner has an allowance rate of 54.1 percent. This rate suggests that roughly half of the applications reach a successful conclusion, indicating a balanced but rigorous review process.
The interview lift of 34.3 percent is a standout figure in this profile. It indicates that conducting an interview significantly improves the likelihood of obtaining an allowance. For the 61 resolved cases on record, this 34.3 percent lift represents a powerful tactical advantage for patent attorneys.
Prosecution under this examiner takes a median of 1188 days to reach an allowance. This duration, combined with the 54.1 percent allowance rate, suggests that patience and strategic communication are required. The high interview lift remains the most actionable data point for navigating the 1188-day timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18911401 | ORAL CARE COMPOSITIONS COMPRISING DICARBOXYLIC ACID | Non-Final OA | The Procter & Gamble Company |
| 18733216 | SKIN CARE COMPOSITION AND METHOD FOR TREATING POST-ACNE MARKS | Final Rejection | The Procter & Gamble Company |
| 18567934 | Micro Carrier, Cell Composite, and Medical Composition, Cosmetic Composition, Medical Articles and Cosmetic Articles Using the Same | Non-Final OA | LG Chem, Ltd. |
| 18634387 | Alkaline Solvent Pre-Wash of Hair For Optimizing Wash Stability of Level 1 Colorations | Final Rejection | Henkel AG & Co. KGaA |
| 18263262 | METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND, A SEALING REAGENT AND A POST-TREATMENT AGENT | Final Rejection | Henkel AG & Co. KGaA |
| 17776186 | LIPOSOME COMPOSITIONS AND METHODS OF TREATMENT TARGETED TO TUMOR ENDOTHELIUM | Non-Final OA | Washington University |
| 17778450 | ORAL PHARMACEUTICAL COMPOSITION COMPRISING CARBAMATE COMPOUND AND PREPARATION METHOD THEREFOR | Final Rejection | SK BIOPHARMACEUTICALS CO., LTD. |
| 18570478 | N-(1,3,4-1-OXADIAZOL-2-YL)PHENYLCARBOXAMIDES AS HERBICIDES | Non-Final OA | BAYER AKTIENGESELLSCHAFT |
| 18270914 | METHODS AND MATERIALS FOR TREATING HAIR LOSS | Final Rejection | The Penn State Research Foundation |
| 18290055 | DRY MICROCARRIER AND METHOD OF MANUFACTURING SAME | Non-Final OA | DAI NIPPON PRINTING CO., LTD. |
| 18549711 | HAIR COLOURING COMPOSITION COMPRISING AT LEAST ONE (POLY)CARBODIIMIDE COMPOUND AND AT LEAST ONE COMPOUND COMPRISING AT LEAST ONE HYDROXYL FUNCTION | Final Rejection | L'Oreal |
| 18091017 | CLEANSING COMPOSITIONS AND METHODS FOR USE | Non-Final OA | L'Oreal |
| 18091009 | CLEANSING COMPOSITIONS AND METHODS FOR USE | Non-Final OA | L'Oreal |
| 17309387 | Personal Care Compositions | Non-Final OA | Colgate-Palmolive Company |
| 18692729 | NANOPARTICLE SURFACE TOPOGRAPHY MODIFIED WITH BOTTLEBRUSH BLOCK COPOLYMERS | Non-Final OA | Yale University |
| 18846467 | A SKIN BRIGHTENING COMPOSITION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18693110 | FRAGRANCE COMPOSITIONS WITH MOISTURIZING BENEFITS | Non-Final OA | Firmenich SA |
| 17999486 | HYDROPHOBIC ANTIMICROBIAL AGENTS | Non-Final OA | OMYA INTERNATIONAL AG |
| 18211886 | INTRAOCULAR DELIVERY OF BIOACTIVE MOLECULES USING IONTOPHORESIS | Non-Final OA | KEMIN INDUSTRIES, INC. |
| 17774777 | Colored particles | Non-Final OA | SYMRISE AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy